Although differences did not reach statistical significance across all outcomes, phenobarbital performed as well as, and in several domains appeared better than, benzodiazepines in this high-risk population, suggesting it represents a viable alternative for the management of severe alcohol withdrawal in patients with advanced liver disease.
← all excerpts
Safety and effectiveness of phenobarbital vs. benzodiazepines for severe alcohol withdrawal in alcohol-associated liver disease in the ICU.
1
—
—